Hydrocortisone

CAS 50-23-7 15 current records 6 historicalSmall Molecule

Who holds supplier records for Hydrocortisone? 15 organisations hold a current record for Hydrocortisone: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 10 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (6), France (1), Spain (1), United States (1) and 2 other countries (2); not recorded for 4.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Hydrocortisone: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/hydrocortisone

Reading the evidence

  • 15 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Hydrocortisone expires 23 Feb 2043. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (15)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Hydrocortisone. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • EUROAPI FRANCE
    Active DMF 2789, 30373 · latest filing Mar 2016
    FranceCEP Company GMP cert on record
  • HENAN LIHUA PHARMACEUTICAL CO LTD
    Active DMF 18944, 38263, 28066 · latest filing Apr 2023
    CEP
  • CURIA SPAIN SAU
    Active DMF 33002 · latest filing Jul 2018
    SpainCEP Company GMP cert on record
  • Pharmacia & Upjohn, Inc.
    Active DMF 1413 · latest filing Sept 1969
    United StatesCEP
  • SHANDONG XINHUA PHARMACEUTICAL CO LTD
    Active DMF 11606, 33073 · latest filing Oct 2018
    ChinaCEP Company GMP cert on record
  • SYMBIOTEC PHARMALAB PRIVATE LTD
    Active DMF 31349 · latest filing Jan 2017
    IndiaCEP Company GMP cert on record
  • ZHEJIANG XIANJU PHARMACEUTICAL CO LTD
    Active DMF 30230 · latest filing Jan 2016
    CEP
  • HIKMA PHARMACEUTICALS
    Active DMF 16089 · latest filing Aug 2002
  • Jiangsu Lianhuan Pharmaceutical Co.,Ltd.
    Active DMF 36074 · latest filing Aug 2021
    China
  • PHARMACIA AND UPJOHN CO WHOLLY OWNED SUB PFIZER INC
    Active DMF 5498 · latest filing Jun 1984
  • SHANGHAI NEW HUALIAN PHARMACEUTICAL CO LTD
    Active DMF 28500 · latest filing Jul 2014
    China
  • TIANJIN TIANYAO PHARMACEUTICALS CO LTD
    Active DMF 35222 · latest filing Nov 2020
    China
  • GermanyCEP Company GMP cert on record
  • TIANJIN JINJIN PHARMACEUTICAL CO., LTD.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    ChinaCEP
  • ZHEJIANG ACINOVA PHARMACEUTICAL CO., LTD.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    ChinaCEP
Need Hydrocortisone sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (10)

Certificates of Suitability on the EDQM register for Hydrocortisone, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 17 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
SYMBIOTEC PHARMALAB LIMITED IndoreIN
CEP 2018-054 - Rev 05
Hydrocortisone, Micronised
Sept 2026Inspected Mar 2026
Germany
CURIA SPAIN S.A.U. BoecilloES
CEP 2018-045 - Rev 04
Hydrocortisone
Jun 2026Inspected Feb 2026
Spain
TIANJIN JINJIN PHARMACEUTICAL CO., LTD. Xiqing DistrictCN
CEP 2015-033 - Rev 01
Hydrocortisone, Micronised, non-micronised
Jun 2026—
ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2018-239 - Rev 03
Hydrocortisone
Jun 2026—
ZHEJIANG ACINOVA PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2017-208 - Rev 04
Hydrocortisone
Mar 2026—
HENAN LIHUA PHARMACEUTICAL CO., LTD. AnyangCN
CEP 2022-264 - Rev 01
Hydrocortisone
Mar 2026—
SHANDONG XINHUA PHARMACEUTICAL CO., LTD. ZiboCN
CEP 2019-176 - Rev 01
Hydrocortisone, Non-micronised, micronised
Jan 2025Inspected Nov 2025
Hungary
EUROAPI FRANCE VertolayeFR
CEP 2019-166 - Rev 03
Hydrocortisone, Micronised
Nov 2024Inspected Jul 2025
France
PHARMACIA & UPJOHN COMPANY LLC KalamazooUS
R1-CEP 2002-220 - Rev 02
Hydrocortisone, Non-micronised, micronised
Mar 2023—
BAYER AG LeverkusenDE
R1-CEP 2000-099 - Rev 02
Hydrocortisone, Micro 20
Mar 2017—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (6)

Organisations whose Type II DMFs for Hydrocortisone are no longer active. These show a past filing, not current supply.

Show all 6 historical records
  • YANGZHOU PHARMACEUTICAL CO LTD
    Inactive DMF 32124 · filed Sept 2017
  • TIANJIN PHARMACEUTICAL PLANT
    Inactive DMF 8269 · filed Oct 1989
  • Germany · Inactive DMF 4757 · filed Nov 1982
  • DIOSYNTH INC
    Inactive DMF 3917 · filed Jul 1980
  • GIST-BROCADES NV PHARMACEUTICALS
    Inactive DMF 1997 · filed Sept 1972
  • NEW DRUG INSTITUTE
    Inactive DMF 199 · filed Jan 1940

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (54 listed products contain Hydrocortisone). The latest listed patent expires 23 Feb 2043. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Hydrocortisone is a corticosteroid hormone that is used to treat inflammation, allergic reactions, and certain types of autoimmune conditions. It mimics the cortisol produced by the adrenal glands, helping to reduce swelling and allergic-type reactions.

Chemical identity

IUPAC name
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
Canonical SMILES
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O
InChIKey
JYGXADMDTFJGBT-ZPOLXVRWSA-N
Synonyms
Cortisol, Oncovin API

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Corticosteroid
Mechanism of action
Corticosteroid Hormone Receptor Agonists

Therapeutic areas

DermatologyEndocrinologyAllergy

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Hydrocortisone?

15 organisations hold an active US FDA Type II Drug Master File or a CEP for Hydrocortisone: EUROAPI FRANCE (France), HENAN LIHUA PHARMACEUTICAL CO LTD, CURIA SPAIN SAU (Spain), Pharmacia & Upjohn, Inc. (United States), SHANDONG XINHUA PHARMACEUTICAL CO LTD (China), SYMBIOTEC PHARMALAB PRIVATE LTD (India), ZHEJIANG XIANJU PHARMACEUTICAL CO LTD and HIKMA PHARMACEUTICALS, and 7 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Hydrocortisone Drug Master Files are active?

EUROAPI FRANCE (DMF 2789, 30373), HENAN LIHUA PHARMACEUTICAL CO LTD (DMF 18944, 38263), CURIA SPAIN SAU (DMF 33002), Pharmacia & Upjohn, Inc. (DMF 1413), SHANDONG XINHUA PHARMACEUTICAL CO LTD (DMF 11606, 33073), SYMBIOTEC PHARMALAB PRIVATE LTD (DMF 31349), ZHEJIANG XIANJU PHARMACEUTICAL CO LTD (DMF 30230) and HIKMA PHARMACEUTICALS (DMF 16089) and 4 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Hydrocortisone records mean?

6 organisations have only inactive Type II DMFs for Hydrocortisone. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Hydrocortisone have a European Certificate of Suitability?

Yes. 10 organisations hold a valid CEP for Hydrocortisone on the EDQM register, including SYMBIOTEC PHARMALAB LIMITED Indore (IN), CURIA SPAIN S.A.U. Boecillo (ES), TIANJIN JINJIN PHARMACEUTICAL CO., LTD. Xiqing District (CN), ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. Taizhou (CN), ZHEJIANG ACINOVA PHARMACEUTICAL CO., LTD. Taizhou (CN) and HENAN LIHUA PHARMACEUTICAL CO., LTD. Anyang (CN) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Hydrocortisone?

Yes. The latest patent listed for an approved US product containing Hydrocortisone expires 23 Feb 2043, across 54 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Hydrocortisone supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Hydrocortisone?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.